drugset / Trial / NCT06081933
Intranasal Dexmedetomidine Versus Intravenous Dexmedetomidine for Improving Quality of Endoscopic Sinus Surgery
RandomizedParallel-groupTriple-blindTreatment
Summary
compare intranasal dexmedetomidine versus intravenous dexmedetomidine for improving quality of the operative field in Functional endoscopic sinus surgery
Timeline
- Start
- 2022-12-20
- Primary completion
- 2023-12-15
- Completion
- 2023-12-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 0.1 ug/kg | Intranasal |
| Subject | Dexmedetomidine | Other / unclassified | 0.4 ug/kg | Intranasal |
| Subject | Dexmedetomidine | Other / unclassified | 1.5 ug/kg | Intranasal |
Indications
No indication recorded.